Article

Richard L. Abbott, MD, begins term as AAO president for 2011

Richard L. Abbott, MD, began his term as president of the American Academy of Ophthalmology (AAO) Jan. 1. Dr. Abbott is the Thomas W. Boyden Health Sciences Clinical Professor of Ophthalmology at the University of California, San Francisco, and research associate at the Francis I. Proctor Foundation. He succeeded Randy Johnston, MD, as AAO president.

San Francisco-Richard L. Abbott, MD, began his term as president of the American Academy of Ophthalmology (AAO) Jan. 1. Dr. Abbott is the Thomas W. Boyden Health Sciences Clinical Professor of Ophthalmology at the University of California, San Francisco, and research associate at the Francis I. Proctor Foundation. He succeeded Randy Johnston, MD, as AAO president.

“Ophthalmology is flourishing, and we are facing more opportunities and challenges than ever before,” Dr. Abbott said. “I look forward to working on issues that are important to our members now, and to inspire them to become future leaders for our profession.”

Dr. Abbott has held numerous leadership positions in the AAO. He most recently was a member of the organization’s Committee of Secretaries, holding the position of secretary for quality care and knowledge base development from 2002 to 2008. He also has served as secretary for quality of care (1994) and as a member of the AAO Board of Trustees as senior secretary for ophthalmic practice (1996 to 2001).

In 2009 and 2010, he served as chairman of the board of the Ophthalmic Mutual Insurance Co. In 2006, Dr. Abbott received the AAO’s Lifetime Achievement Award, and in 2008, he was elected into Academia Ophthalmologica Internationalis.

Dr. Abbott received his medical degree in 1971 from the George Washington University School of Medicine. After completing his internship at Los Angeles County Hospital, he spent 2 years in the Indian Public Health Service teaching medics and running a community health clinic on the Navajo reservation. He completed his fellowship in corneal and external diseases at the Bascom Palmer Eye Institute in Miami.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.